Leptin treatment is considered to be ineffective in the general population of patients with obesity and/or type 2 diabetes due to development of leptin resistance, hyperleptinemia, and insulin resistance [52]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.